The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. MaxCyte Inc.’s current trading price is -53.07% away from its 52-week high, while its distance from the 52-week low is 2.03%. The stock’s price range for this period has been between $3.45 and $7.50 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 0.56 million for the day, a number notably higher than the average daily volume of 0.38 million over the last three months.
The present stock price for MaxCyte Inc. (MXCT) is $3.52. In the last trading session, the stock made a considerable jump, reaching $3.77 after an opening price of $3.74. The stock briefly fell to $3.51 before ending the session at $3.76.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
In terms of market performance, MaxCyte Inc. had a fairly uneven. The highest value for the stock in the past year was $7.50 on 10/04/22, and the lowest value was recorded at $3.45 on 08/25/23.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
MaxCyte Inc. (MXCT) has experienced a quarterly decline of -29.60% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 351.61M and boasts a workforce of 125 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 4.34, with a change in price of -1.49. Similarly, MaxCyte Inc. recorded 434,309 in trading volume during the last 100 days, posting a change of -29.74%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for MXCT stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
MXCT Stock Stochastic Average
MaxCyte Inc.’s raw stochastic average for the past 50 days is presently 4.00%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 17.50%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 56.77% and 57.77%, respectively.
MXCT Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The index has shown a price loss of -35.53% this year. Over the last six months, there has been a stronger performance of -13.94%. The price of MXCT leaped by -8.33% during the last 30 days period. For the last 5-days stocks have slided -3.56%.
